Clinical characteristics and predictive factors of survival of 761 cancer patients on home parenteral nutrition: A prospective, cohort study

Paolo Cotogni(Azienda Ospedaliero Universitaria San Giovanni Battista), Antonella De Francesco(Azienda Ospedaliero Universitaria San Giovanni Battista), Taira Monge(Azienda Ospedaliero Universitaria San Giovanni Battista), Laura Brossa(Fondazione Ricerca Molinette), Roberto Passera(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino)
Cancer Medicine
May 15, 2020
10.1002/cam4.3064
Cited by 29

Related Papers

Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
|Journal of Clinical Oncology|2015|2.2k
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disorders
|Leukemia|2013|305
Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients
|Blood|2011|268
Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma
|Journal of Clinical Oncology|2010|268
Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage
|Blood|2008|253